Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | -5.85% | -5.01% | +5.23% |
Apr. 22 | Transcript : Lexicon Pharmaceuticals, Inc. - Analyst/Investor Day | |
Mar. 25 | Lexicon Pharmaceuticals Files Prospectus for Secondary Offering | MT |
Financials (USD)
Sales 2024 * | 25.81M | Sales 2025 * | 77.52M | Capitalization | 396M |
---|---|---|---|---|---|
Net income 2024 * | -199M | Net income 2025 * | -193M | EV / Sales 2024 * | 15.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.11 x |
P/E ratio 2024 * |
-2.41
x | P/E ratio 2025 * |
-2.7
x | Employees | 285 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.99% |
Latest transcript on Lexicon Pharmaceuticals, Inc.
1 day | -5.85% | ||
1 week | -5.01% | ||
Current month | -32.92% | ||
1 month | -24.06% | ||
3 months | +0.62% | ||
6 months | +47.71% | ||
Current year | +5.23% |
Managers | Title | Age | Since |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 14-07-06 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 98-12-31 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 21-08-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01-01-31 |
Ray Debbane
CHM | Chairman | 69 | 07-07-31 |
Director/Board Member | 65 | 07-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +5.94% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.61 | -5.85% | 3,555,268 |
24-04-22 | 1.71 | +3.64% | 4,093,358 |
24-04-19 | 1.65 | +1.23% | 2,991,230 |
24-04-18 | 1.63 | +0.62% | 3,715,007 |
24-04-17 | 1.62 | -4.42% | 5,561,536 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.23% | 421M | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- LXRX Stock